Brittany McDowell
Family · Palm Beach Gardens, FLNPI 1477952133
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 327 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 327 payments — averaging $22.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$953
- Lilly USA, LLC$655
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$542
- Amgen$531
- Pfizer$453
- plus $3K from 32 others
What the payments were for
- Food & beverage$7,422100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 61 | $1,155 |
| Novo Nordisk | 44 | $953 |
| Lilly USA, LLC | 39 | $655 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $542 |
| Amgen | 24 | $531 |
| Pfizer | 25 | $453 |
| Optinose US, Inc. | 9 | $308 |
| Teva Pharmaceuticals USA, Inc. | 6 | $246 |
| Biohaven Pharmaceuticals, Inc. | 8 | $228 |
| GSK | 3 | $228 |
| Antares Pharma, Inc. | 6 | $206 |
| AstraZeneca | 5 | $205 |
| Exact Sciences | 9 | $183 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $167 |
| Abbott | 2 | $151 |
| Radius Health, Inc. | 6 | $144 |
| Neurocrine Biosciences, Inc. | 4 | $133 |
| Medtronic | 1 | $129 |
| Novartis | 7 | $127 |
| Sanofi-aventis U.S. LLC | 3 | $77 |
| Myriad Women's Health, Inc. | 1 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| IBSA Pharma Inc. | 3 | $61 |
| Eisai Inc. | 3 | $56 |
| Sanofi | 1 | $43 |
| Insmed, Inc. | 2 | $41 |
| Amarin Pharma, Inc. | 2 | $37 |
| Astellas Pharma US Inc | 1 | $33 |
| Amneal Pharmaceuticals LLC | 2 | $33 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Bayer | 1 | $20 |
| Merz North America, Inc. | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Halozyme Inc | 1 | $15 |
| Tolmar, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,422 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 40 | $59,329 |
| MounjaroTirzepatide | 34 | $41,706 |
| JardianceEmpagliflozin | 17 | $22,841 |
| Repatha SureclickEvolocumab | 20 | $19,227 |
| Rosuvastatin Calcium | 204 | $1,833 |
| Levothyroxine Sodium | 80 | $1,124 |
| SynthroidLevothyroxine Sodium | 16 | $1,090 |
| Duloxetine Hcl | 19 | $989 |
| Valsartan | 15 | $637 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $574 |
| Metoprolol Succinate | 41 | $486 |
| Fluticasone Propionate | 28 | $482 |
| Atorvastatin Calcium | 83 | $438 |
| Lisinopril | 83 | $433 |
| Bupropion XlBupropion Hcl | 16 | $416 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $953 | $59,32940 claims |
| Lilly USA, LLCMounjaro | $655 | $41,70634 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $33 | $1,12480 claims |
| AbbVieSynthroid | $1,155 | $1,09016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.
Other family in Palm Beach Gardens
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.